How does vaccine-induced immunity affect poliovirus transmission dynamics?

• A. IPV-induced immunity reduces disease risk but has no effect on mucosal transmission
• B. OPV-induced intestinal immunity reduces shedding and transmission; IPV-induced immunity reduces disease risk but has less impact on mucosal transmission
• C. OPV reduces shedding; IPV eliminates transmission completely
• D. Neither vaccine affects transmission dynamics

Answer: (B)

Understanding how vaccine-induced immunity shapes poliovirus spread starts with the difference between mucosal immunity in the gut and systemic immunity in the blood. The gut is where the virus replicates and is shed in feces, so reduced gut replication translates directly into less transmission.

The oral polio vaccine is a live attenuated vaccine that colonizes the intestine and elicits strong mucosal immunity, including secretory IgA. This mucosal response lowers intestinal replication and viral shedding, making person-to-person transmission less likely.

In contrast, the injected inactivated polio vaccine mainly boosts systemic neutralizing antibodies that protect against paralytic disease but don’t establish strong mucosal immunity in the gut. People vaccinated with this form are well protected from disease, but if exposed, can still support viral replication and shedding, so transmission is not as greatly reduced.

Thus, the combination in the statement is accurate: the OPV component reduces shedding and transmission through intestinal immunity, while the IPV component reduces disease risk via systemic immunity but has less impact on mucosal transmission.